Denmark's Novo Nordisk said on Monday it is confident that its proposed takeover of U.S. drugmaker Metsera does not raise any antitrust issues.
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning for anyone taking Ozempic, Wegovy, ...
1hon MSN
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors ...
"Every day, I got on the scales and I still weighed exactly the same as before," Leith, 85, told U.K. paper 'The Times' ...
It made the call for anyone suffering from a 'severe reaction' to GLP-1 medicine. According to the Government website, glucagon-like peptide-1 receptor agonists (GLP-1s) are medicines that help people ...
The same survey also found that weight loss drugs such as Ozempic and Wegovy – known as GLP-1 (glucagon-like peptide-1) drugs ...
Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...
HELLO! Speaks to three board-certified surgeons, Dr Asif Pirani, Dr Raj Dedhia, and Dr Anthony Berlet to unpack the science ...
But the results add to evidence from animal studies and reports that people are finding drugs like Ozempic and Wegovy helpful to manage cravings, not just for food, but also for tobacco and alcohol.
Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for ...
Popular weight-loss drugs like Ozempic and Zepbound may offer more than just help shedding extra pounds—they might also help protect people from serious health risks linked to sleep apnea. That’s the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results